OXAZOLIDINE CABAZITAXEL
UNII 4VS94YZ6W3

Substance Identification & Data

This profile provides standardized clinical and technical data for Oxazolidine Cabazitaxel, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4VS94YZ6W3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1373171-12-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

4VS94YZ6W3

CAS Registry Number

1373171-12-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

OXAZOLIDINE CABAZITAXEL

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C48H61NO14

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

WGEFOIHAXGTXJE-RTMVWDMESA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

71551062

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

O(C(C)=O)[C@]12[C@]3([C@H](OC(=O)c4ccccc4)[C@@]5(O)C(C)(C)C([C@@H](OC)C(=O)[C@]3(C)[C@@H](OC)C[C@]1(OC2)[H])=C(C)[C@@H](OC(=O)[C@H]6[C@@H](N(C(OC(C)(C)C)=O)C(C)(C)O6)c7ccccc7)C5)[H]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Oxazolidine Cabazitaxel. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

OXAZOLIDINE CABAZITAXEL

Systematic Nomenclature

3,5-OXAZOLIDINEDICARBOXYLIC ACID, 2,2-DIMETHYL-4-PHENYL-, 5-((2AR,4S,4AS,6R,9S,11S,12S,12AR,12BS)-12B-(ACETYLOXY)-12-(BENZOYLOXY)-2A,3,4,4A,5,6,9,10,11,12,12A,12B-DODECAHYDRO-11-HYDROXY-4,6-DIMETHOXY-4A,8,13,13-TETRAMETHYL-5-OXO-7,11-METHANO-1H-CYCLODECA(3,4)BENZ(1,2-B)OXET-9-YL) 3-(1,1-DIMETHYLETHYL) ESTER, (4S,5R)-

SYS

4-ACETOXY-2A-BENZOYLOXY-5.BETA.-20-EPOXY-1-HYDROXY-9-OXO-7.BETA.,10.BETA.-DIMETHOXY-11-TAXEN-13-YL (4S,5R)-3-(TERT-BUTYLCARBONYL)-2,2-DIMETHYL-4-PHENYL-5-OXAZOLIDINECARBOXYLATE

SYS

5-((2AR,4S,4AS,6R,9S,11S,12S,12AR,12BS)-12B-(ACETYLOXY)-12-(BENZOYLOXY)-2A,3,4,4A,5,6,9,10,11,12,12A,12B-DODECAHYDRO-11-HYDROXY-4,6-DIMETHOXY-4A,8,13,13-TETRAMETHYL-5-OXO-7,11-METHANO-1H-CYCLODECA(3,4)BENZ(1,2-B)OXET-9-YL) 3-(1,1-DIMETHYLETHYL) (4S,5R)-2,2-DIMETHYL-4-PHENYL-3,5-OXAZOLIDINEDICARBOXYLATE

SYS

External Clinical & Regulatory Resources

Previous UNII4VS908W98L

Next UNII4VSD7Q7FUH